Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation.

We evaluated the efficacy and the safety of medium-(240 mn/day) and high-dose (360 mg/day) diltiazem alone and in combination with digoxin when used for control of heart rate in 12 patients with chronic atrial fibrillation. Medium-dose diltiazem was comparable to therapeutic dose of digoxin at rest (88 +/- 19 vs 86 +/- 12 beats/min) but superior during peak exercise (154 +/- 23 vs 170 +/- 20 beats/min; p less than .05). High-dose diltiazem resulted in better control of heart rate than digoxin both at rest (79 +/- 17 beats/min; p less than .05) and exercise (136 +/- 25 beats/min; p less than .05) but was associated with side effects in 75% of the patients. Combined therapy of digoxin and diltiazem enhanced the effect of digoxin alone and resulted in significantly better control of heart rate at rest (67 +/- beats/min with medium-dose and 65 +/- beats/min with high-dose diltiazem) and during peak exercise (132 +/- 32 and 121 +/- 24 beats/min, respectively). However, the difference in heart rate between these two doses was not significant. Reduction of heart rate combined with concomitant effect on blood pressure resulted in a significant fall in pressure-rate product at rest from 10,077 +/- 1708 mm Hg/min on digoxin alone to 7877 +/- 1818 mm Hg/min after the addition of medium-dose diltiazem (p less than .05) and during exercise form 25,670 +/- 3606 to 18,439 +/- 4115 mm Hg/min (p less than .05). Continued therapy with digoxin combined with diltiazem 240 mg/day for 21 +/- 8 days in nine patients showed persistent effect on heart rate and blood pressure without any toxic manifestations or change in serum digoxin (1.5 +/- 0.4 vs 1.3 +/- 0.4 ng/ml) or plasma diltiazem concentrations (204 +/- 72 vs 232 +/- 129 ng/ml). In conclusion, medium-dose diltiazem when combined with digoxin is an effective and safe regimen for the treatment of patients with chronic atrial fibrillation and enhances digoxin-mediated control of heart rate both at rest and during exercise.

[1]  C. McKay,et al.  Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. , 1985, The American journal of cardiology.

[2]  K. Tordjman,et al.  Nifedipine-induced periorbital edema. , 1985, The American journal of cardiology.

[3]  U. Elkayam,et al.  Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease. , 1985, The American journal of cardiology.

[4]  F. Meijler.  An "account" of digitalis and atrial fibrillation. , 1985, Journal of the American College of Cardiology.

[5]  D. Magometschnigg,et al.  The diltiazem‐digoxin interaction , 1984, Clinical pharmacology and therapeutics.

[6]  C. Porter,et al.  Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. , 1984, Journal of the American College of Cardiology.

[7]  S. Bertil Olsson,et al.  Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation , 1984, Clinical cardiology.

[8]  R. O'rourke,et al.  Short- and long-term efficacy of high-dose oral diltiazem for angina due to coronary artery disease: a placebo-controlled, randomized, double-blind crossover study. , 1983, Circulation.

[9]  E. Pritchett,et al.  Pharmacokinetic and pharmacodynamic effects of diltiazem. , 1983, The American journal of cardiology.

[10]  G. Belz,et al.  Interaction between digoxin and calcium antagonists and antiarrhythmic drugs , 1983, Clinical pharmacology and therapeutics.

[11]  E. Kaplinsky,et al.  Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. , 1983, Chest.

[12]  E. Kaplinsky,et al.  Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction. , 1982, The American journal of cardiology.

[13]  R. Terry,et al.  Nifedipine therapy in angina pectoris: evaluation of safety and side effects. , 1982, American heart journal.

[14]  D. Harrison,et al.  Acute and Chronic Pharmacodynamic Interaction of Verapamil and Digoxin in Atrial Fibrillation , 1982, Circulation.

[15]  E. Kaplinsky,et al.  The Influence of Verapamil on Serum Digoxin Concentration , 1982, Circulation.

[16]  I. Wiener,et al.  Clinical use of oral verapamil in chronic and paroxysmal atrial fibrillation. , 1982, Chest.

[17]  L. Rydén,et al.  Comparison of metoprolol and verapamil in the treatment of angina pectoris. , 1982, The American journal of cardiology.

[18]  H. Hecht,et al.  Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. , 1981, The American journal of cardiology.

[19]  P. D. Henry.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. , 1980, The American journal of cardiology.

[20]  P. Probst,et al.  Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. , 1975, The American journal of cardiology.

[21]  J. Ross,et al.  Velocity of contraction as a determinant of myocardial oxygen consumption. , 1965, The American journal of physiology.

[22]  D. Singer,et al.  Effects of digitalis on electrical activity of cardiac fibers , 1964 .

[23]  E. H. Skinner,et al.  Diseases of the Heart , 1936, The Indian Medical Gazette.

[24]  E. P. Lewis.  PSYCHIATRY IN EDUCATION. By V. V. Anderson, M. D., M. A. (New York and London : Harper and Brothers, 1932.) , 1934 .

[25]  K. Theisen,et al.  Effect of the calcium antagonist diltiazem on atrioventricular conduction in chronic atrial fibrillation. , 1985, The American journal of cardiology.

[26]  E. Pritchett,et al.  High-performance liquid chromatographic analysis of diltiazem and its metabolite in plasma. , 1983, Journal of chromatography.

[27]  J. Mason,et al.  Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review. , 1982, The American journal of cardiology.

[28]  J. Mason,et al.  Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients. , 1982, American heart journal.

[29]  R. Bruce.  Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. , 1971, Annals of clinical research.